Search results
Results from the Tech24 Deals Content Network
Post-exposure prophylaxis, also known as post-exposure prevention ( PEP ), is any preventive medical treatment started after exposure to a pathogen in order to prevent the infection from occurring. It should be contrasted with pre-exposure prophylaxis, which is used before the patient has been exposed to the infective agent.
platelet-activating factor. paroxysmal atrial fibrillation (meaning intermittent AF) PAH. pulmonary arterial hypertension. phenylalanine hydroxylase. PAI-1. plasminogen activator inhibitor-1. PAL. posterior axillary line.
The Healthcare Effectiveness Data and Information Set ( HEDIS) is a widely used set of performance measures in the managed care industry, developed and maintained by the National Committee for Quality Assurance (NCQA). HEDIS was designed to allow consumers to compare health plan performance to other plans and to national or regional benchmarks.
(Reuters) - The Centers for Medicare & Medicaid Services said in a memo on Thursday it will recalculate the quality ratings of Medicare Advantage plans for people aged 65 years and above, which ...
The management of HIV/AIDS normally includes the use of multiple antiretroviral drugs as a strategy to control HIV infection. [ 1] There are several classes of antiretroviral agents that act on different stages of the HIV life-cycle. The use of multiple drugs that act on different viral targets is known as highly active antiretroviral therapy ...
CHART #2: SIDE-BY-SIDE COMPARISON OF DEMOCRATIC CANDIDATESÕ HEALTH PLANS. CHART #2: SIDE-BY-SIDE COMPARISON OF DEMOCRATIC CANDIDATES’ HEALTH PLANS. By Susan J. Blumenthal, M.D., Jessica B. Rubin, Michelle E. Treseler, Jefferson Lin, and David Mattos*. Stated Goals for Coverage. Joe Biden. Chris Dodd.
Part B covers doctor visits and tests, outpatient care, home health services, and medical equipment. The standard monthly premium amount for Part B in 2023 is $164.90 and applies to those with a ...
Polyestradiol phosphate (PEP), sold under the brand name Estradurin, is an estrogen medication which is used primarily in the treatment of prostate cancer in men. [1] [9] [2] [10] It is also used in women to treat breast cancer, as a component of hormone therapy to treat low estrogen levels and menopausal symptoms, and as a component of feminizing hormone therapy for transgender women.